Now showing items 31-33 of 33
Developing drugs for developing countries.
(Health Aff (Millwood), 2006-03)
Infectious and parasitic diseases create enormous health burdens, but because most of the people suffering from these diseases are poor, little is invested in developing treatments. We propose that developers of treatments ...
R&D costs and returns by therapeutic category
(Drug Information Journal, 2004-09-03)
Objectives: This study examines the degree to which therapeutic class accounts for variability in drug development costs. It also scrutinizes how sales levels vary across the associated therapeutic classes for those drugs ...
Mergers and Alliances in Pharmaceutical: Effects on Innovation and R&D Productivity
(The Economics of Corporate Governance and Mergers, 2008-01-01)
This book provides an insightful view of major issues in the economics of corporate governance (CG) and mergers. It presents a systematic update on the developments in the two fields during the last decade, as well ...